Home Page
Second class of Sam Taylor life sciences scholarship recipients named
The second class of recipients of the Samuel M. Taylor Memorial Life Sciences Scholarship in the NC Community Colleges Foundation have been named. This year, five scholarships have been awarded.
Read MorePart D drug price “negotiation” comes at cost of jobs, investment, cures
Congress passed the Inflation Reduction Act on Aug. 12. Included in the law is a provision that gives Medicare Part D the ability to “negotiate” the price of medicines for the first time. Negotiate is in quotation marks because lawmakers are being ironic; no one can legitimately call the new price-setting policy a negotiation.
Read MoreLab Space Forum discusses tight supply, innovative solutions to lab space shortage
Strategies for meeting the booming demand for lab space in the Triangle and across North Carolina were shared and discussed by panelists from Azzur Group, Lee & Associates, Longfellow Real Estate Partners and Lincoln Harris at the NCBIO Lab Space Forum and Luncheon held Thursday, July 14, at the NC Biotechnology Center.
Read MoreNorth Carolina unified in attracting new ARPA-H headquarters to the state
Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for Health headquarters to North Carolina.
Read More2022 Legislative Reception (photo gallery)
NCBIO held its 2022 Legislative Reception on Wednesday, June 22, at the North Carolina Museum of History in Raleigh. The event was well attended by NCBIO members who were joined by a number of state senators, including Life Science Caucus Co-Chair Sen. Mike Woodard and Sens. Lisa Barnes, Sydney Batch, Steve Jarvis and Joyce Waddell.
Read MoreSupply chain during pandemic discussed at June Biotech Manufacturers Forum meeting
Representatives of Merck and NCBIO discussed the supply-chain difficulties and issues the COVID-19 pandemic created for the bioscience industry at the quarterly NCBIO Biomanufacturers Forum meeting held Wednesday, June 1, at the NC Biotechnology Center.
Read MoreMedical Device Forum discusses current FDA regulatory environment
NCBIO members got an overview of the Food and Drug Administration’s regulatory environment for medical devices both during the pandemic and now at the NCBIO Medical Device Forum held May 11 at the NC Biotechnology Center.
Read MoreLead gifts from Alexandria Real Estate, Biogen, Hatteras push Taylor scholarship fund past $200,000
The Samuel M. Taylor Memorial Scholarship Fund created by NCBIO at the North Carolina Community Colleges Foundation Inc. has exceeded $200,000 in gifts and pledges with leadership gifts coming from Alexandria Real Estate Equities, Biogen and Hatteras Venture Partners.
Read MoreBIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy
BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the Biogen’s Alzheimer’s disease treatment Aduhelm — along with other drugs like it — to clinical trials. Michelle McMurry-Heath, M.D., Ph.D., president and…
Read MoreNCBIO forum explores moving technology through funding phases
A high quality board of directors and valuable outside partnerships are two advantages that biotech startups would do well to cultivate, according to the expert panelists assembled for the NCBIO Emerging Company and Technology Forum held Wednesday, March 16, at the NC Biotechnology Center.
Read More